Improved RhCMV/SIV Vaccine Efficacy via IL-10 Pathway Modulation

Grant

Date/time Interval

  • September 24, 2018 - August 31, 2023
  • Total Award Amount

  • 132331.00
  • Direct Costs

  • 89112.00
  • Sponsor Award Id

  • A19-1756-S001
  • Contributor

  • Mark Walter Ph.D.   Principal Investigator